Print

NovaBay Pharmaceuticals, Inc. (NBY) Appoints Mark M. Sieczkarek, Solta Medical, Inc. (SLTM) Chairman And CEO And Dr. Massimo Radaelli, Noventia Pharma CEO To Its Board Of Directors  
1/9/2014 9:45:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., Jan. 9 2014 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, has appointed Mark M. Sieczkarek and Dr. Massimo Radaelli to its Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

//-->